2022/11/29 更新

写真a

ヤノ マサト
矢野 真人
YANO Masato
所属
教育研究院 医歯学系 医学系列 准教授
医歯学総合研究科 生体機能調節医学専攻 感覚統合医学 准教授
職名
准教授
▶ researchmapのプロフィールを表示
外部リンク

学位

  • 博士(医学) ( 2005年3月   大阪大学 )

研究キーワード

  • RNAプロセッシング

  • HITS-CLIP

  • RNA結合蛋白質

  • 非コードRNA

  • 神経変性疾患

  • 分子神経生物学

  • 包括脳ネットワーク

研究分野

  • ライフサイエンス / 分子生物学

  • ライフサイエンス / 神経科学一般

  • ライフサイエンス / 病態神経科学

経歴(researchmap)

  • 慶應義塾大学   医学部生理学教室   訪問准教授

    2014年12月 - 現在

      詳細を見る

  • 新潟大学   大学院医歯学総合研究科   准教授

    2014年12月 - 現在

      詳細を見る

  • 慶應義塾大学   医学部   講師

    2011年10月 - 2014年11月

      詳細を見る

  • ロックフェラー大学   ポスドク

    2006年 - 2011年

      詳細を見る

  • 慶應義塾大学   日本学術振興会特別研究員

    2005年

      詳細を見る

経歴

  • 新潟大学   医歯学総合研究科 生体機能調節医学専攻 感覚統合医学   准教授

    2014年12月 - 現在

学歴

  • 大阪大学   大学院医学系研究科

    - 2005年3月

      詳細を見る

  • 東京工業大学   生命理工学部

    - 1999年3月

      詳細を見る

所属学協会

委員歴

  • 日本RNA学会   会計幹事  

    2015年4月 - 2019年   

      詳細を見る

    団体区分:学協会

    researchmap

 

論文

  • Involvement of ferroptosis in human motor neuron cell death. 査読 国際誌

    Tsuyoshi Matsuo, Keiko Adachi-Tominari, Osamu Sano, Takayuki Kamei, Masahiro Nogami, Kazuhiro Ogi, Hideyuki Okano, Masato Yano

    Biochemical and biophysical research communications   566   24 - 29   2021年6月

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Ferroptosis was recently defined as a novel type of programmed cell death depending on iron and lipid peroxidation. It is biologically different from other types of cell death such as apoptosis. While the involvement of ferroptosis in cancer, patient and animal model have been intensely studied, ferroptosis in human motor neuron model is still clearly unknown. Here we carefully assessed ferroptosis using human iPS cell-derived motor neuron (hiMNs). We found that almost all hiMNs died by the treatment of glutathione peroxidase 4 (GPX4) inhibitors. Importantly, the cell death was rescued by one antioxidant, vitamin E acetate, iron chelators and lipid peroxidase inhibitors with high dynamic ranges. Finally, these data clearly indicated that ferroptosis constitutively occurs in hiMNs, suggesting the possibility that it might play a biologically and pathologically important roles in motor neuron death such as motor neuron disease (MND)/Amyotrophic lateral sclerosis (ALS).

    DOI: 10.1016/j.bbrc.2021.05.095

    PubMed

    researchmap

  • Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN. 査読 国際誌

    Masahiro Nogami, Mitsuru Ishikawa, Atsushi Doi, Osamu Sano, Takefumi Sone, Tetsuya Akiyama, Masashi Aoki, Atsushi Nakanishi, Kazuhiro Ogi, Masato Yano, Hideyuki Okano

    Neurobiology of disease   155   105364 - 105364   2021年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Fused in sarcoma/translated in liposarcoma (FUS) is a causative gene of amyotrophic lateral sclerosis (ALS). Mutated FUS causes accumulation of DNA damage and cytosolic stress granule (SG) formation, thereby motor neuron (MN) death. However, key molecular aetiology remains unclear. Here, we applied a novel platform technology, iBRN, "Non- biased" Bayesian gene regulatory network analysis based on induced pluripotent stem cell (iPSC)-derived cell model, to elucidate the molecular aetiology using transcriptome of iPSC-derived MNs harboring FUSH517D. iBRN revealed "hub molecules", which strongly influenced transcriptome network, such as miR-125b-5p-TIMELESS axis and PRKDC for the molecular aetiology. Next, we confirmed miR-125b-5p-TIMELESS axis in FUSH517D MNs such that miR-125b-5p regulated several DNA repair-related genes including TIMELESS. In addition, we validated both introduction of miR-125b-5p and knocking down of TIMELESS caused DNA damage in the cell culture model. Furthermore, PRKDC was strongly associated with FUS mis-localization into SGs by DNA damage under impaired DNA-PK activity. Collectively, our iBRN strategy provides the first compelling evidence to elucidate molecular aetiology in neurodegenerative diseases.

    DOI: 10.1016/j.nbd.2021.105364

    PubMed

    researchmap

  • DGCR8-dependent efficient pri-miRNA processing of human pri-miR-9-2 査読

    Masahiro Nogami, Kazumasa Miyamoto, Yoshika Hayakawa-Yano, Atsushi Nakanishi, Masato Yano, Hideyuki Okano

    Journal of Biological Chemistry   296   100409 - 100409   2021年

     詳細を見る

    担当区分:責任著者   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.jbc.2021.100409

    researchmap

  • Analysis of the nucleocytoplasmic shuttling RNA-binding protein HNRNPU using optimized HITS-CLIP method 査読 国際誌

    Yugami M, Okano H, Nakanishi A, Yano M

    PLos One   15 ( 4 )   e0231450   2020年4月

     詳細を見る

    担当区分:最終著者, 責任著者  

    DOI: 10.1371/journal.pone.0231450

    researchmap

  • An RNA Switch of a Large Exon of Ninein Is Regulated by the Neural Stem Cell Specific-RNA Binding Protein, Qki5. 査読

    Hayakawa-Yano Y, Yano M

    International journal of molecular sciences   20 ( 5 )   2019年2月

     詳細を見る

    担当区分:最終著者, 責任著者  

    DOI: 10.3390/ijms20051010

    PubMed

    researchmap

  • An RNA-binding protein, Qki5, regulates embryonic neural stem cells through pre-mRNA processing in cell adhesion signaling 査読

    Hayakawa-Yano Y, Suyama S, Nogami M, Yugami M, Koya I, Zhou L, Abe M, Sakimura K, Takebayashi H, Nakanishi A, Okano H, Yano M

    GENES & DEVELOPMENT   31 ( 18 )   1910 - 1925   2017年9月

     詳細を見る

    担当区分:最終著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT  

    Cell type-specific transcriptomes are enabled by the action of multiple regulators, which are frequently expressed within restricted tissue regions. In the present study, we identify one such regulator, Quaking 5 (Qki5), as an RNA-binding protein (RNABP) that is expressed in early embryonic neural stem cells and subsequently down-regulated during neurogenesis. mRNA sequencing analysis in neural stem cell culture indicates that Qki proteins play supporting roles in the neural stem cell transcriptome and various forms of mRNA processing that may result from regionally restricted expression and subcellular localization. Also, our in utero electroporation gain-of-function study suggests that the nuclear-type Qki isoform Qki5 supports the neural stem cell state. We next performed in vivo transcriptome-wide protein-RNA interaction mapping to search for direct targets of Qki5 and elucidate how Qki5 regulates neural stem cell function. Combined with our transcriptome analysis, this mapping analysis yielded a bona fide map of Qki5-RNA interaction at single-nucleotide resolution, the identification of 892 Qki5 direct target genes, and an accurate Qki5-dependent alternative splicing rule in the developing brain. Last, our target gene list provides the first compelling evidence that Qki5 is associated with specific biological events; namely, cell-cell adhesion. This prediction was confirmed by histological analysis of mice in which Qki proteins were genetically ablated, which revealed disruption of the apical surface of the lateral wall in the developing brain. These data collectively indicate that Qki5 regulates communication between neural stem cells by mediating numerous RNA processing events and suggest new links between splicing regulation and neural stem cell states.

    DOI: 10.1101/gad.300822.117

    Web of Science

    PubMed

    researchmap

  • RNA regulation went wrong in neurodevelopmental disorders: The example of Msi/Elavl RNA binding proteins 査読

    Masato Yano, Yoshika Hayakawa-Yano, Hideyuki Okano

    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE   55   124 - 130   2016年12月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    RNA regulation participates in many aspects of brain development. There is substantial evidence that RNA dysregulation is critical in the pathogenesis of neurodevelopmental disorders, neurological diseases, and cancer. Several gene families encode RNA-binding proteins (RNABPs) that bind directly to RNA and orchestrate the post-transcriptional regulation of gene expression, including pre-mRNA splicing, stability, and poly(A) site usage. Among neural RNABPs, the Elavl and Msi families are the focus of neuronal development research owing to their hierarchical expression pattern: Msi1 is expressed in neural progenitor/stem cells, Elavl2 is expressed in early neuronal progenitors to mature neurons, and Elavl3/4 expression begins slightly later, during cortical neuron development. Traditional biochemical analyses provide mechanistic insight into RNA regulation by these RNABPs, and Drosophila and mouse genetic studies support a relationship between these RNABPs and several neurodevelopmental disorders. In addition, a recent cohort analysis of the human genome shows that genetic mutations and SNPs in these RNABPs are associated with various neurological disorders. Newly emerged technologies assess transcriptome-wide RNA-protein interactions in vivo. These technologies, combined with classical genetics methods, provide new insight into Elavl and Msi, not only with respect to their neurodevelopmental functions, but also their roles in several diseases. We review recent discoveries related to the two RNABP families in brain development and disease. (C) 2016 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.ijdevneu.2016.01.002

    Web of Science

    PubMed

    researchmap

  • Musashi mediates translational repression of the Drosophila hypoxia inducible factor 査読

    Agustina P. Bertolin, Maximiliano J. Katz, Masato Yano, Berta Pozzi, Julieta M. Acevedo, Dalmiro Blanco-Obregon, Lautaro Gandara, Eleonora Sorianello, Hiroshi Kanda, Hideyuki Okano, Anabella Srebrow, Pablo Wappner

    NUCLEIC ACIDS RESEARCH   44 ( 16 )   7555 - 7567   2016年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS  

    Adaptation to hypoxia depends on a conserved alpha/beta heterodimeric transcription factor called Hypoxia Inducible Factor (HIF), whose alpha-subunit is regulated by oxygen through different concurrent mechanisms. In this study, we have identified the RNA binding protein dMusashi, as a negative regulator of the fly HIF homologue Sima. Genetic interaction assays suggested that dMusashi participates of the HIF pathway, and molecular studies carried out in Drosophila cell cultures showed that dMusashi recognizes a Musashi Binding Element in the 3' UTR of the HIF alpha transcript, thereby mediating its translational repression in normoxia. In hypoxic conditions dMusashi is downregulated, lifting HIF alpha repression and contributing to trigger HIF-dependent gene expression. Analysis performed in mouse brains revealed that murine Msi1 protein physically interacts with HIF-1 alpha transcript, suggesting that the regulation of HIF by Msi might be conserved in mammalian systems. Thus, Musashi is a novel regulator of HIF that inhibits responses to hypoxia specifically when oxygen is available.

    DOI: 10.1093/nar/gkw372

    Web of Science

    PubMed

    researchmap

  • Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma 査読

    Raymond G. Fox, Nikki K. Lytle, Dawn V. Jaquish, Frederick D. Park, Takahiro Ito, Jeevisha Bajaj, Claire S. Koechlein, Bryan Zimdahl, Masato Yano, Janel L. Kopp, Marcie Kritzik, Jason K. Sicklick, Maike Sander, Paul M. Grandgenett, Michael A. Hollingsworth, Shinsuke Shibata, Donald Pizzo, Mark A. Valasek, Roman Sasik, Miriam Scadeng, Hideyuki Okano, Youngsoo Kim, A. Robert MacLeod, Andrew M. Lowy, Tannishtha Reya

    NATURE   534 ( 7607 )   407 - +   2016年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Pancreatic intraepithelial neoplasia is a pre-malignant lesion that can progress to pancreatic ductal adenocarcinoma, a highly lethal malignancy marked by its late stage at clinical presentation and profound drug resistance1. The genomic alterations that commonly occur in pancreatic cancer include activation of KRAS2 and inactivation of p53 and SMAD4 (refs 2-4). So far, however, it has been challenging to target these pathways therapeutically; thus the search for other key mediators of pancreatic cancer growth remains an important endeavour. Here we show that the stem cell determinant Musashi (Msi) is a critical element of pancreatic cancer progression both in genetic models and in patient-derived xenografts. Specifically, we developed Msi reporter mice that allowed image-based tracking of stem cell signals within cancers, revealing that Msi expression rises as pancreatic intraepithelial neoplasia progresses to adenocarcinoma, and that Msi-expressing cells are key drivers of pancreatic cancer: they preferentially harbour the capacity to propagate adenocarcinoma, are enriched in circulating tumour cells, and are markedly drug resistant. This population could be effectively targeted by deletion of either Msi1 or Msi2, which led to a striking defect in the progression of pancreatic intraepithelial neoplasia to adenocarcinoma and an improvement in overall survival. Msi inhibition also blocked the growth of primary patient-derived tumours, suggesting that this signal is required for human disease. To define the translational potential of this work we developed antisense oligonucleotides against Msi; these showed reliable tumour penetration, uptake and target inhibition, and effectively blocked pancreatic cancer growth. Collectively, these studies highlight Msi reporters as a unique tool to identify therapy resistance, and define Msi signalling as a central regulator of pancreatic cancer.

    DOI: 10.1038/nature17988

    Web of Science

    PubMed

    researchmap

  • Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells. 査読 国際誌

    Ichiyanagi N, Fujimori K, Yano M, Ishihara-Fujisaki C, Sone T, Akiyama T, Okada Y, Akamatsu W, Matsumoto T, Ishikawa M, Nishimoto Y, Ishihara Y, Sakuma T, Yamamoto T, Tsuiji H, Suzuki N, Warita H, Aoki M, Okano H

    Stem cell reports   6 ( 4 )   496 - 510   2016年4月

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.stemcr.2016.02.011

    PubMed

    researchmap

  • Acute reduction of neuronal RNA binding Elavl2 protein and Gap43 mRNA in mouse hippocampus after kainic acid treatment 査読

    Takafumi Ohtsuka, Masato Yano, Hideyuki Okano

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   466 ( 1 )   46 - 51   2015年10月

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Activity-dependent gene regulation in neurons has been hypothesized to be under transcriptional control and to include dramatic increases in immediate early genes (IEGs) after neuronal activity. In addition, several reports have focused on post-transcriptional regulation, which could be mediated by neuronal post-transcriptional regulators, including RNA binding proteins (RNABPs). One such protein family is the neuronal Elavls (nElavls; Elavl2, Elavl3, and Elavl4), whose members are widely expressed in peripheral and central nervous system. Previous reports showed that Elavl3 and 4 are up-regulated following repeated stimulation such as during cocaine administration, a seizure, or a spatial discrimination task. In this study, we focused on Elavl2, a candidate gene for schizophrenia and studied its role in neuronal activity. First we found that Elavl2 has a cell-type specific expression pattern that is highly expressed in hippocampal CA3 pyramidal neurons and hilar interneurons using Elavl2 specific antibody. Second, unexpectedly, we discovered that the Elavl2 protein level in the hippocampus was acutely downregulated for 3 h after a kainic acid (KA)-induced seizure in the hippocampal CA3 region. In addition, level of Gap43 mRNA, a target mRNA of Elavl2 is decreased 12 h after KA treatment, thus suggesting the involvement of Elavl2 in activity-dependent RNA regulation. (C) 2015 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2015.08.103

    Web of Science

    PubMed

    researchmap

  • RNA-binding protein research with transcriptome-wide technologies in neural development 査読

    Masato Yano, Takafumi Ohtsuka, Hideyuki Okano

    CELL AND TISSUE RESEARCH   359 ( 1 )   135 - 144   2015年1月

     詳細を見る

    担当区分:責任著者   記述言語:英語   出版者・発行元:SPRINGER  

    An increasing number of studies have demonstrated that neural RNA-binding proteins (nRNABPs) participate in several steps of neural development through post-transcriptional regulation of their RNA targets (Grabowski Curr Opin Genet Dev 21:388-394, 2011). Classical genetics and in vitro biochemical approaches have identified several important RNA targets of nRNABPs linked to cell-fate decision and neuronal functions. In recent years, new technologies, such as unbiased in vivo protein-RNA interaction approaches, high-throughput sequencing-cross-linked immunoprecipitation (HITS-CLIP), microarrays, RNAseq and others, have been developed. The use of these with genetics has succeeded in defining a dynamic range of RNA targets of RNABPs at the transcriptome-wide level. This new platform also provides the mechanistic insights into a specific biological function of nRNABPs. This review highlights the discoveries and challenges of the interplay between the nRNABPs and their biological functions in neural development.

    DOI: 10.1007/s00441-014-1923-8

    Web of Science

    PubMed

    researchmap

  • Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain 査読

    Donny D. Licatalosi, Masato Yano, John J. Fak, Aldo Mele, Sarah E. Grabinski, Chaolin Zhang, Robert B. Darnell

    GENES & DEVELOPMENT   26 ( 14 )   1626 - 1642   2012年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT  

    Two polypyrimidine tract RNA-binding proteins (PTBs), one near-ubiquitously expressed (Ptbp1) and another highly tissue-restricted (Ptbp2), regulate RNA in interrelated but incompletely understood ways. Ptbp1, a splicing regulator, is replaced in the brain and differentiated neuronal cell lines by Ptbp2. To define the roles of Ptbp2 in the nervous system, we generated two independent Ptbp2-null strains, unexpectedly revealing that Ptbp2 is expressed in neuronal progenitors and is essential for postnatal survival. A HITS-CLIP (high-throughput sequencing cross-linking immunoprecipitation)-generated map of reproducible Ptbp2-RNA interactions in the developing mouse neocortex, combined with results from splicing-sensitive microarrays, demonstrated that the major action of Ptbp2 is to inhibit adult-specific alternative exons by binding pyrimidine-rich sequences upstream of and/or within them. These regulated exons are present in mRNAs encoding proteins associated with control of cell fate, proliferation, and the actin cytoskeleton, suggesting a role for Ptbp2 in neurogenesis. Indeed, neuronal progenitors in the Ptbp2-null brain exhibited an aberrant polarity and were associated with regions of premature neurogenesis and reduced progenitor pools. Thus, Ptbp2 inhibition of a discrete set of adult neuronal exons underlies early brain development prior to neuronal differentiation and is essential for postnatal survival.

    DOI: 10.1101/gad.191338.112

    Web of Science

    PubMed

    researchmap

  • Nova2 Regulates Neuronal Migration through an RNA Switch in Disabled-1 Signaling 査読

    Masato Yano, Yoshika Hayakawa-Yano, Aldo Mele, Robert B. Darnell

    NEURON   66 ( 6 )   848 - 858   2010年6月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    Neuronal migration leads to a highly organized laminar structure in the mammalian brain, and its misregulation causes lissencephaly and behavioral and cognitive defects. Reelin signaling, which is mediated in part by a key adaptor, disabled-1 (Dab1), plays a critical but incompletely understood role in this process. We found that the neuron-specific RNA-binding protein Nova2 regulates neuronal migration in late-generated cortical and Purkinje neurons. An unbiased HITS-CLIP and exon junction array search for Nova-dependent reelin-pathway RNAs at E14.5 revealed only one candidate-an alternatively spliced isoform of Dab1 (Dab1.7bc). In utero electroporation demonstrated that Dab1.7bc was sufficient to induce neuronal migration defects in wild-type mice and exacerbate defects when Dab1 levels were reduced, whereas Dab1 overexpression mitigates defects in Nova2 null mice. Thus, Nova2 regulates an RNA switch controlling the ability of Dab1 to mediate neuronal responsiveness to reelin signaling and neuronal migration, suggesting new links between splicing regulation, brain disease, and development.

    DOI: 10.1016/j.neuron.2010.05.007

    Web of Science

    PubMed

    researchmap

  • Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation 査読

    M Yano, HJ Okano, H Okano

    JOURNAL OF BIOLOGICAL CHEMISTRY   280 ( 13 )   12690 - 12699   2005年4月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    The Hu family is a group of neuronal RNA-binding proteins required for neuronal differentiation in the developing nervous system. Previously, Hu proteins have been shown to enhance the stabilization and/or translation of target mRNAs, such as p21 ( CIP1), by binding to AU-rich elements in untranslated regions ( UTRs). In this study, we show that Hu induces p21 expression, cell cycle arrest, and neuronal differentiation in mouse neuroblastoma N1E-115 cells. p21 expression is also up-regulated during Me2SO- induced differentiation in N1E-115 cells and is controlled by post-transcriptional mechanisms through its 3'-UTR. To investigate the molecular mechanisms of Hu functions, we used a proteomics strategy to isolate Hu-interacting proteins and identified heterogeneous nuclear ribonucleoprotein (hnRNP) K. hnRNP K also specifically binds to CU-rich sequences in p21 mRNA 3'-UTR and represses its translation in both nonneuronal and neuronal cells. Further, using RNA interference experiments, we show that the Hu-p21 pathway contributes to the regulation of neurite outgrowth and proliferation in N1E-115 cells, and this pathway is antagonized by hnRNP K. Our results suggest a model in which the mutually antagonistic action of two RNA-binding proteins, Hu and hnRNP K, control the timing of the switch from proliferation to neuronal differentiation through the post-transcriptional regulation of p21 mRNA.

    DOI: 10.1074/jbc.M411119200

    Web of Science

    PubMed

    researchmap

  • The RNA-binding protein HuD regulates neuronal cell identity and maturation 査読

    W Akamatsu, H Fujihara, T Mitsuhashi, M Yano, S Shibata, Y Hayakawa, HJ Okano, S Sakakibara, H Takano, T Takano, T Takahashi, T Noda, H Okano

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   102 ( 12 )   4625 - 4630   2005年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATL ACAD SCIENCES  

    Neural Hu proteins (HuB/C/D) are RNA-binding proteins that have been shown to induce neuronal differentiation activity when overexpressed in immature neural progenitor cells or undifferentiated neuronal tumors. Newly generated HuD-deficient mice exhibited a transient impaired-cranial-nerve-development phenotype at an early embryonic stage. Adult HuD-deficient mice exhibited an abnormal hind-limb reflex and poor rotarod performance. Analysis of neurosphere formation revealed that the number and self-renewal capacity of the neural stem/progenitor cells were increased in HuD-deficient mice. HuD-deficient primary neurospheres also generated a smaller number of neurons. Cohort analysis of the cellular proliferative activity by using BrdUrd and iododeoxuridine labeling revealed that the number of differentiating quiescent cells in the embryonic cerebral wall was decreased. Long-term administration of BrdUrd revealed that the number of slowly dividing stem cells in the adult subventricular zone was increased in the HuD-deficient mice. Taken together, the results suggest that HuD is required at multiple points during neuronal development, including negative regulation of proliferative activity and neuronal cell-fate acquisition of neural stem/progenitor cells.

    DOI: 10.1073/pnas.0407523102

    Web of Science

    PubMed

    researchmap

  • Diverse dystonin gene mutations cause distinct patterns of Dst isoform deficiency and phenotypic heterogeneity in Dystonia musculorum mice. 査読 国際誌

    Nozomu Yoshioka, Yudai Kabata, Momona Kuriyama, Norihisa Bizen, Li Zhou, Dang M Tran, Masato Yano, Atsushi Yoshiki, Tatsuo Ushiki, Thomas J Sproule, Riichiro Abe, Hirohide Takebayashi

    Disease models & mechanisms   13 ( 5 )   2020年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Loss-of-function mutations in dystonin (DST) can cause hereditary sensory and autonomic neuropathy type 6 (HSAN-VI) or epidermolysis bullosa simplex (EBS). Recently, DST-related diseases were recognized to be more complex than previously thought because a patient exhibited both neurological and skin manifestations, whereas others display only one or the other. A single DST locus produces at least three major DST isoforms: DST-a (neuronal isoform), DST-b (muscular isoform) and DST-e (epithelial isoform). Dystonia musculorum (dt) mice, which have mutations in Dst, were originally identified as spontaneous mutants displaying neurological phenotypes. To reveal the mechanisms underlying the phenotypic heterogeneity of DST-related diseases, we investigated two mutant strains with different mutations: a spontaneous Dst mutant (Dstdt-23Rbrc mice) and a gene-trap mutant (DstGt mice). The Dstdt-23Rbrc allele possesses a nonsense mutation in an exon shared by all Dst isoforms. The DstGt allele is predicted to inactivate Dst-a and Dst-b isoforms but not Dst-e There was a decrease in the levels of Dst-a mRNA in the neural tissue of both Dstdt-23Rbrc and DstGt homozygotes. Loss of sensory and autonomic nerve ends in the skin was observed in both Dstdt-23Rbrc and DstGt mice at postnatal stages. In contrast, Dst-e mRNA expression was reduced in the skin of Dstdt-23Rbrc mice but not in DstGt mice. Expression levels of Dst proteins in neural and cutaneous tissues correlated with Dst mRNAs. Because Dst-e encodes a structural protein in hemidesmosomes (HDs), we performed transmission electron microscopy. Lack of inner plaques and loss of keratin filament invasions underneath the HDs were observed in the basal keratinocytes of Dstdt-23Rbrc mice but not in those of DstGt mice; thus, the distinct phenotype of the skin of Dstdt-23Rbrc mice could be because of failure of Dst-e expression. These results indicate that distinct mutations within the Dst locus can cause different loss-of-function patterns among Dst isoforms, which accounts for the heterogeneous neural and skin phenotypes in dt mice and DST-related diseases.

    DOI: 10.1242/dmm.041608

    PubMed

    researchmap

  • Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs. 査読 国際誌

    Kazunari Onodera, Daisuke Shimojo, Yasuharu Ishihara, Masato Yano, Fuyuki Miya, Haruhiko Banno, Naoko Kuzumaki, Takuji Ito, Rina Okada, Bruno de Araújo Herculano, Manabu Ohyama, Mari Yoshida, Tatsuhiko Tsunoda, Masahisa Katsuno, Manabu Doyu, Gen Sobue, Hideyuki Okano, Yohei Okada

    Molecular brain   13 ( 1 )   18 - 18   2020年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Spinal bulbar muscular atrophy (SBMA) is an adult-onset, slowly progressive motor neuron disease caused by abnormal CAG repeat expansion in the androgen receptor (AR) gene. Although ligand (testosterone)-dependent mutant AR aggregation has been shown to play important roles in motor neuronal degeneration by the analyses of transgenic mice models and in vitro cell culture models, the underlying disease mechanisms remain to be fully elucidated because of the discrepancy between model mice and SBMA patients. Thus, novel human disease models that recapitulate SBMA patients' pathology more accurately are required for more precise pathophysiological analysis and the development of novel therapeutics. Here, we established disease specific iPSCs from four SBMA patients, and differentiated them into spinal motor neurons. To investigate motor neuron specific pathology, we purified iPSC-derived motor neurons using flow cytometry and cell sorting based on the motor neuron specific reporter, HB9e438::Venus, and proceeded to the genome-wide transcriptome analysis by RNA sequences. The results revealed the involvement of the pathology associated with synapses, epigenetics, and endoplasmic reticulum (ER) in SBMA. Notably, we demonstrated the involvement of the neuromuscular synapse via significant upregulation of Synaptotagmin, R-Spondin2 (RSPO2), and WNT ligands in motor neurons derived from SBMA patients, which are known to be associated with neuromuscular junction (NMJ) formation and acetylcholine receptor (AChR) clustering. These aberrant gene expression in neuromuscular synapses might represent a novel therapeutic target for SBMA.

    DOI: 10.1186/s13041-020-0561-1

    PubMed

    researchmap

  • Elavl3 regulates neuronal polarity through the alternative splicing of an embryo-specific exon in AnkyrinG 査読

    Yuki Ogawa, Junji Yamaguchi, Masato Yano, Yasuo Uchiyama, Hirotaka James Okano

    Neuroscience Research   135   13 - 20   2018年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier Ireland Ltd  

    Alternative splicing of RNAs diversifies the functionalities of proteins, and it is optimized for each cell type and each developmental stage. nElavl (composed of Elavl2, Elavl3, and Elavl4) proteins are the RNA-binding proteins that is specifically expressed in neurons, regulate the alternative splicing of target RNAs, and promote neuronal differentiation and maturation. Recent studies revealed that Elavl3 knockout (Elavl3−/−) mice completely lost the expression of nElavl proteins in the Purkinje cells and exhibited cerebellar dysfunction. Here, we found that the alternative splicing of AnkyrinG exon 34 was misregulated in the cerebella of Elavl3−/− mice. AnkyrinG is an essential factor for the formation of neuronal polarity and is required for normal neuronal functions. We revealed that exon 34 of AnkyrinG was normally included in immature neurons and was mostly excluded in mature neurons
    however, it was included in the cerebella of Elavl3−/− mice even in adulthood. In the Purkinje cells of adult Elavl3−/− mice, the length of the AnkyrinG-positive region shortened and somatic organelles leaked into the axons. These results suggested that exon 34 of AnkyrinG is an embryonic-stage-preferential exon that should be excluded from mature neurons and that Elavl3 regulates neuronal polarity through alternative splicing of this exon.

    DOI: 10.1016/j.neures.2018.03.008

    Scopus

    PubMed

    researchmap

  • Analysis of induced pluripotent stem cells carrying 22q11.2 deletion. 査読 国際誌

    M Toyoshima, W Akamatsu, Y Okada, T Ohnishi, S Balan, Y Hisano, Y Iwayama, T Toyota, T Matsumoto, N Itasaka, S Sugiyama, M Tanaka, M Yano, B Dean, H Okano, T Yoshikawa

    Translational psychiatry   6 ( 11 )   e934   2016年11月

     詳細を見る

    記述言語:英語  

    Given the complexity and heterogeneity of the genomic architecture underlying schizophrenia, molecular analyses of these patients with defined and large effect-size genomic defects could provide valuable clues. We established human-induced pluripotent stem cells from two schizophrenia patients with the 22q11.2 deletion (two cell lines from each subject, total of four cell lines) and three controls (total of four cell lines). Neurosphere size, neural differentiation efficiency, neurite outgrowth, cellular migration and the neurogenic-to-gliogenic competence ratio were significantly reduced in patient-derived cells. As an underlying mechanism, we focused on the role of DGCR8, a key gene for microRNA (miRNA) processing and mapped in the deleted region. In mice, Dgcr8 hetero-knockout is known to show a similar phenotype of reduced neurosphere size (Ouchi et al., 2013). The miRNA profiling detected reduced expression levels of miRNAs belonging to miR-17/92 cluster and miR-106a/b in the patient-derived neurospheres. Those miRNAs are reported to target p38α, and conformingly the levels of p38α were upregulated in the patient-derived cells. p38α is known to drive gliogenic differentiation. The inhibition of p38 activity by SB203580 in patient-derived neurospheres partially restored neurogenic competence. Furthermore, we detected elevated expression of GFAP, a gliogenic (astrocyte) marker, in postmortem brains from schizophrenia patients without the 22q11.2 deletion, whereas inflammation markers (IL1B and IL6) remained unchanged. In contrast, a neuronal marker, MAP2 expressions were decreased in schizophrenia brains. These results suggest that a dysregulated balance of neurogenic-to-gliogenic competence may underlie neurodevelopmental disorders such as schizophrenia.

    DOI: 10.1038/tp.2016.206

    PubMed

    researchmap

  • Alternative Role of HuD Splicing Variants in Neuronal Differentiation 査読

    Satoru Hayashi, Masato Yano, Mana Igarashi, Hirotaka James Okano, Hideyuki Okano

    JOURNAL OF NEUROSCIENCE RESEARCH   93 ( 3 )   399 - 409   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    HuD is a neuronal RNA-binding protein that plays an important role in neuronal differentiation of the nervous system. HuD has been reported to have three RNA recognition motifs (RRMs) and three splice variants (SVs) that differ in their amino acid sequences between RRM2 and RRM3. This study investigates whether these SVs have specific roles in neuronal differentiation. In primary neural epithelial cells under differentiating conditions, HuD splice variant 1 (HuD-sv1), which is a general form, and HuD-sv2 were expressed at all tested times, whereas HuD-sv4 was transiently expressed at the beginning of differentiation, indicating that HuD-sv4 might play a role compared different from that of HuD-sv1. Indeed, HuD-sv4 did not promote neuronal differentiation in epithelial cells, whereas HuD-sv1 did promote neuronal differentiation. HuD-sv4 overexpression showed less neurite-inducing activity than HuD-sv1 in mouse neuroblastoma N1E-115 cells; however, HuD-sv4 showed stronger growth-arresting activity. HuD-sv1 was localized only in the cytoplasm, whereas HuD-sv4 was localized in both the cytoplasm and the nuclei. The Hu protein has been reported to be involved in translation and alternative splicing in the cytoplasm and nuclei, respectively. Consistent with this observation, HuD-sv1 showed translational activity on p21, which plays a role in growth arrest and neuronal differentiation, whereas HuD-sv4 did not. By contrast, HuD-sv4 showed stronger pre-mRNA splicing activity than did HuD-sv1 on Clasp2, which participates in cell division. Therefore, HuD SVs might play a role in controlling the timing of proliferation/differentiation switching by controlling the translation and alternative splicing of target genes. (c) 2014 Wiley Periodicals, Inc.

    DOI: 10.1002/jnr.23496

    Web of Science

    PubMed

    researchmap

  • Characterization of the RNA-binding protein Musashi1 in zebrafish 査読

    Shinsuke Shibata, Masahiko Umei, Hironori Kawahara, Masato Yano, Shinji Makino, Hideyuki Okano

    BRAIN RESEARCH   1462   162 - 173   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Musashi (Msi) is an evolutionarily conserved gene family of RNA-binding proteins (RBPs) that is preferentially expressed in the nervous system. The first member of the Msi family was identified in Drosophila. Drosophila Msi plays an important role in regulating asymmetric cell division of the sensory organ precursor cells. The mammalian orthologs, including human and mouse Musashi1 (Msi1), are neural RBPs that are strongly expressed in fetal and adult neural stem/progenitor cells (NS/PCs). Mammalian Msi1 contributes to self renewal of NS/PCs through translational regulation of several target mRNAs. In this study, the zebrafish Msi ortholog zMsi1 was identified and characterized. The normal spatial and temporal expression profiles for both protein and mRNA were determined. A series of splice variants were detected. Overall, zMsi1 was strongly expressed in neural tissue in early stages of development and exhibited similarity to mammalian Msi1 expression patterns. To reveal the in vivo function of zMsi1, morpholinos against Msi1 were introduced into one-cell stage zebrafish embryos. Knock down of zmsi1 frequently resulted in aberrant formation of the Central Nervous System (CNS). These results suggest that Msi1 plays roles in CNS development in vertebrates.
    This article is part of a Special Issue entitled "RNA-Binding Proteins". (c) 2012 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.brainres.2012.01.068

    Web of Science

    PubMed

    researchmap

  • [Roles of RNA binding proteins in neural development]. 査読

    Yano M, Okano HJ, Okano H

    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme   51 ( 16 Suppl )   2603 - 2608   2006年12月

     詳細を見る

  • Sox21 is a repressor of neuronal differentiation and is antagonized by YB-1 査読

    H Ohba, T Chiyoda, E Endo, M Yano, Y Hayakawa, M Sakaguchi, RB Darnell, HJ Okano, H Okano

    NEUROSCIENCE LETTERS   358 ( 3 )   157 - 160   2004年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCI IRELAND LTD  

    Sox21, a high-mobility group box transcription factor, is expressed throughout the immature neural stem/progenitor population in ventricular zone but not in the cortical plate in embryonic mouse brain and its expression is restricted to the subventricular zone in the adult brain. In undifferentiated PC 12 cells, endogenous Sox21 expression is detected but its expression ceases during the nerve growth factor (NGF)-induced neuronal differentiation. Overexpression of Sox21 results in a substantial repression of NGF-induced neurite outgrowth in PC12 cells. Further, we biochemically identified a Sox21-associating protein, Y-box binding protein I which not only binds to Sox21 but also partially restores NGF-induced neurite outgrowth of PC12 cells inhibited by Sox21. These results suggest that Sox21 is a repressor of neuronal differentiation in the developing nervous system. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.neulet.2004.01.026

    Web of Science

    PubMed

    researchmap

  • 12(S)-hydroxyeicosatetraenoic acid induces cAMP production via increasing intracellular calcium concentration 査読

    G Hasegawa, S Kumagai, M Yano, YG Wang, Y Kobayashi, Y Saito

    FEBS LETTERS   554 ( 1-2 )   127 - 132   2003年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    We have found that a 12-lipoxygenase metabolite of arachidonic acid, 12(S)-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acid (12-HETE), induces CAMP production in human normal fibroblast TIG-1 cells. This phenomenon was not observed in other cells tested including human embryonic kidney HEK293 cells. We have speculated that this specific response might be influenced by the kinds of isoform of adenylyl cyclase (AC) present in cells. We found that TIG-1 cells specifically expressed type VIII AC. As type VIII AC is known to be activated by an increase of calcium concentration, we determined the change of intracellular Ca2+ concentration after the addition of 12-HETE. It was elevated not only in TIG-1 cells, but also HEK293 cells, which did not respond to 12-HETE to produce CAMP. The addition of a calcium ionophore elevated the concentration of intracellular CAMP in TIG-1 cells, but it was without effect in HEK293 cells. To show that the expression of this particular isoform of AC is responsible for the positive response to 12-HETE, we transfected this AC isoform into HEK293 cells. The type VIII AC-transfected cells, in contrast to the mock-transfected ones, became very responsive to 12HETE to produce CAMP. Taken all together the data would strongly suggest that 12-HETE specifically activates type VIII AC via increasing intracellular Ca2+ concentration. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

    DOI: 10.1016/S0014-5793(03)01128-1

    Web of Science

    PubMed

    researchmap

▶ 全件表示

書籍等出版物

  • カンデル神経科学

    矢野真人, 岡野栄之( 担当: 共訳 ,  範囲: 3章 遺伝子と行動)

    株式会社 メディカル・サイエンス・インターナショナル  2014年 

     詳細を見る

  • わかる実験医学シリーズ 転写がわかる 基本転写から発生,再生,先端医療まで 半田 宏/編

    矢野真人, 岡野栄之( 担当: 共著 ,  範囲: 転写制御による神経系の分化)

    実験医学  2004年 

     詳細を見る

MISC

  • 【白血病学(下)-最新の基礎、臨床研究-】 白血病の基礎研究と臨床研究の動向 造血幹細胞と白血病幹細胞研究の動向 幹細胞と癌における細胞運命決定因子Musashiの役割

    矢野 真人, 岡野 栄之

    日本臨床   74 ( 増刊10 白血病学(下) )   503 - 507   2016年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)日本臨床社  

    researchmap

  • RNA結合蛋白質の機能解析最前線

    矢野 真人

    新潟医学会雑誌   130 ( 2 )   79 - 84   2016年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:新潟医学会  

    researchmap

  • ncRNA研究をはじめよう 9.RNP解析 1):CLIP―CLIP技術の進化と今後の展開

    矢野真人, 矢野佳芳

    実験医学   33 ( 20 )   3419 - 3423   2015年12月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • HITS-CLIP法; トランスクリプトームワイド 蛋白質-RNA相互作用のin vivoフットプリンティング

    矢野真人, 矢野佳芳

    日本RNA学会HP   2014年12月

     詳細を見る

  • RNA疾患―最新の病態解析から治療法展望まで―脳内における蛋白質‐RNA相互作用の検出とその応用

    大塚貴文, 矢野真人, 岡野栄之

    月刊メディカル・サイエンス・ダイジェスト   40 ( 7 )   326 - 329   2014年6月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 幹細胞制御の分子基盤【幹細胞制御とRNAネットワーク】

    矢野真人, 岡野栄之

    細胞   44 ( 9 )   381 - 384   2012年8月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • RNAの解析〈RNA解析の新技術〉HITS‐CLIP法を用いた選択的スプライシングとmiRNAの制御マップ解析

    矢野真人

    臨床検査   55 ( 9 )   865 - 871   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:医学書院  

    DOI: 10.11477/mf.1542102724

    CiNii Article

    CiNii Books

    J-GLOBAL

    researchmap

  • クローズアップ実験法 Series210 HITS‐CLIP法:タンパク質‐RNA相互作用のゲノムワイドマッピング

    矢野真人, 矢野(早川)佳芳, DARNELL Robert B

    実験医学   29 ( 1 )   105 - 114   2011年1月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • A role of neuronal RNA binding protein Hu and NF45/NF90 in the nervous system

    Mana Igarashi, Masato Yano, James Hirotaka Okano, Hideyuki Okano

    NEUROSCIENCE RESEARCH   65   S90 - S90   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.368

    Web of Science

    researchmap

  • ROLES OF RNA BINDING PROTEIN Hu IN DEVELOPING AND MATURE NEURONS

    Hirotaka James Okano, Kyoko Kakumoto, Masato Yano, Robert B. Darnell, Hideyuki Okano

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   343 - 343   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:SPRINGER TOKYO  

    Web of Science

    researchmap

  • A role of neuronal RNA-binding protein Hu and NF45/90 in the nervous system

    Mania Igarashi, Masato Yano, Hirotaka J. Okano, Hideyuki Okano

    NEUROSCIENCE RESEARCH   61   S153 - S153   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • Altered participation in neural differentiation by HuD splice variants

    Satoru Hayashi, Masato Yano, Mana Igarashi, Hiroyuki Miyoshi, Hirotaka James Okano, Hideyuki Okano

    NEUROSCIENCE RESEARCH   61   S229 - S229   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • RNAと高次生命現象 神経系の発生とRNA結合蛋白質

    矢野真人, 岡野ジェイムス洋尚, 岡野栄之

    蛋白質 核酸 酵素   51 ( 16 )   2603 - 2608   2006年12月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • A role of neuronal RNA binding protein Hu and NF45/90 in the nervous system

    Mana Igarashi, Masato Yano, Satoru Hayashi, Hirotaka J. Okano, Hideyuki Okano

    NEUROSCIENCE RESEARCH   55   S145 - S145   2006年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

▶ 全件表示

講演・口頭発表等

  • 蛋白質-RNA相互作用マッピングによる新しいRNA制御モデル解明とRNA制御オリゴの同定 招待

    矢野真人

    第42回日本分子生物学会 ワークショップ "RNA結合蛋白質解析の成せる用と美"  2019年12月 

     詳細を見る

  • RNA結合蛋白質による選択的スプライシング制御からみた神経発生機構 招待

    矢野真人

    第6回JCRベーシックリサーチカンファレンス  2019年10月 

     詳細を見る

  • 神経系におけるHITS-CLIP解析に基づいた新しいRNA制御機構の解明とその応用の可能性 招待

    矢野真人

    第27回東京医科歯科大学・システム発生・再生医学分野セミナー  2019年10月 

     詳細を見る

  • 蛋白質-RNA相互作用マッピングは、新しいRNA制御モデルとRNA制御オリゴの同定を可能にする 招待

    矢野真人

    第18回日本再生医療学会シンポジウム「RNA技術と幹細胞研究の最前線  2019年3月 

     詳細を見る

    会議種別:シンポジウム・ワークショップ パネル(指名)  

    researchmap

  • 中枢神経系の細胞アイデンティティーを創出する RNA 結合蛋白質の解析 招待

    矢野真人

    武田薬品工業SILエキスパートシンポジウム”RNA-Binding Proteins in Neuroscience”  2018年7月 

     詳細を見る

    会議種別:シンポジウム・ワークショップ パネル(指名)  

    researchmap

  • Cell-type specific RNA-binding proteins in the developing central nervous system” 招待

    矢野真人

    第41回日本神経科学大会シンポジウム RNA制御から理解する神経発生と疾患  2018年7月 

     詳細を見る

    会議種別:シンポジウム・ワークショップ パネル(指名)  

    researchmap

  • Alternative splicing in neural stem cells 招待

    矢野真人, 矢野佳芳, 岡野栄之

    第39回日本分子生物学会 RNA結合蛋白質による細胞運命制御  2016年11月 

     詳細を見る

    会議種別:シンポジウム・ワークショップ パネル(指名)  

    researchmap

  • 神経発生・疾患とRNA結合蛋白質 招待

    矢野真人

    第46回新潟神経学夏期セミナー RNAと神経疾患  2016年7月 

     詳細を見る

  • 高解像度RNA制御を介した神経系細胞機能の解析 招待

    矢野真人

    大分大学テニュアトラックセミナー  2015年3月 

     詳細を見る

  • Transcriptome wide mapping of Msi1-RNA interaction in neural stem cell 招待

    矢野真人, 岡野栄之

    第37回分子生物学会年会シンポジウムMolecular Biology of Non-coding RNAs and its Application  2014年11月 

     詳細を見る

  • RNA 結合蛋白質 Musashi による幹細胞機能の転写後レベルでの調節機構 招待

    岡野栄之, 矢野真人

    第37回日本神経科学大会 シンポジウム  2014年9月 

     詳細を見る

▶ 全件表示

受賞

  • 宇宙兄弟ALSプロジェクトせりか基金賞

    2019年12月  

    矢野真人

     詳細を見る

  • 三四会奨励賞

    2014年   慶應義塾大学  

    矢野真人

     詳細を見る

  • 第55回ノーベル賞受賞者会議(リンダウ会議)文部科学省選抜派遣者

    2005年6月  

     詳細を見る

共同研究・競争的資金等の研究

  • 神経変性疾患におけるエニグマティックRNA群の操作と治療応用

    2020年3月 - 2021年9月

    武田薬品工業  COCKPI-Tプロジェクト 

    矢野真人

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • 脊髄運動ニューロン固有のRNA制御プログラムとALS病態の関連

    2019年 - 2022年

    文部科学省: 科学研究費補助金(基盤研究(B)) 

    矢野真人

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • オーファンCLIPed-ncRNA作動エレメントの神経系における意義の解明

    2017年 - 2018年

    文部科学省  科学研究費補助金(新学術領域研究(研究領域提案型)) 

    矢野 真人

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • Elavl2による脳内翻訳制御機構の解析

    2016年 - 2018年

    文部科学省  科学研究費補助金(基盤研究 (C)) 

    矢野 真人

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • 遺伝学およびマルチオミクス戦略による神経疾患関連新規RNA結合蛋白質の探索と機能解析

    2015年4月 - 2018年3月

    武田薬品工業  2nd SIL湘南インキュベーションラボプロジェクト 

    矢野真人

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • Musashi1ーRNA相互作用ゲノムマッピング

    研究課題/領域番号:24700333  2012年 - 2013年

    文部科学省  科学研究費補助金(若手研究(B))  若手研究(B)

    矢野 真人

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:4420000円 ( 直接経費:3400000円 、 間接経費:1020000円 )

    researchmap

▶ 全件表示

その他研究活動

  • Editorial Board: Frontiers in Molecular Neuroscience

    2020年6月

     詳細を見る